Clinical trial · Observational
BCC Excision Revisited
Long-term Results After Surgical Basal Cell Carcinoma Excision in the Eyelid Region: Revisited
NCT05853315CI-TRIAL-00066479completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To readdress basal cell carcinoma (BCC) in the periocular region to prove histologically controlled surgical treatment efficacy and to identify high-risk characteristics.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
| Eye Cancer | Malignant Eye Neoplasm | ALIAS | 0.90 |
| Eye Diseases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- BCC Recurrence
- timeFrame
- mean 3-5 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion criteria: * Patient records were reviewed for the presence of BCC and surgical excision with frozen sections control of the wound margins in the periocular region, * conducted between 01.01.2009 and 31.12.2019. * Periocular was defined as the area involving the medial and lateral canthus as well as the upper and lower eyelids. Exclusion criteria: * BCCs outside of this region were excluded from this analysis, * as well as incomplete records.
References
Publications (0)
Data not yet available
No reference posted for this study.